CanaccordStill looking for close to a triple given the crazy decline in SP. GLTA
Canaccord Genuity analyst Matt Bottomley cut his Ayr Wellness Inc. target to $62 from $70 with a “buy” rating. The average is $68.67.
“Although we have trimmed our forward valuation, we note that AYR.A still trades at 5.6 times our 2022E EV/EBITDA- a significant discount to its MSO peers at 8.5 times, making it one of the better value propositions in the space (in our view),” he said.